Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Dinushika Mohottige, MD, a general nephrologist and assistant professor at the ICAHN School of Medicine at Mount Sinai, discusses the causes, symptoms, and treatments of kidney disease. The…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses treatment options for end-stage kidney disease, also known as end-stage renal disease. The treatments include dialysis, transplantation, or medical management,…
